CORT CORT

Q: What is the current share price of CORT?

As of 2026-08-05 17:25 PDT, CORT trades at $110.69 on NASDAQ/NYSE. Its 52-week range is $32.15 to $118.32.

Q: What is the market capitalisation of CORT?

CORT has a market capitalisation of $15.78B on NASDAQ/NYSE.

Q: What is the P/E ratio of CORT?

CORT trades at a trailing price-to-earnings (P/E) ratio of 134.99. Its price-to-book (P/B) ratio is 24.35.

Q: What is the return on equity (ROE) of CORT?

CORT has a return on equity (ROE) of 15.38%. Its return on capital employed (ROCE) is 6.68%.

Q: Is CORT a good stock to buy?

This page provides a data-driven analysis of CORT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Company Profile ↓

$110.69

+54.23% 1Y

Mkt Cap$15.78B

P/E134.99

P/B24.35

52W High$118.32

52W Low$32.15

Book Value$4.55

EPS (TTM)$0.82

Company Overview

CORT (CORT) is a publicly traded company listed on with a market capitalization of $15.78B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 15.4%, reflecting efficient use of shareholder capital.

Steady Revenue Expansion

Revenue has grown at a 118.8% CAGR over the past five years.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $761.41M (+12.8% YoY); net profit $99.65M.
Trailing 12 Months Year-on-year growth — revenue +12.8%, earnings -29.4%.
5-Year Trend Long-term compounding — revenue CAGR 118.8%, profit CAGR 1.1%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	118.75%
1 Year:	12.79%

Compounded Profit Growth

5 Years:	1.14%
1 Year:	-29.43%

Stock Price Performance

1 Year:	+54.23%
6 Months:	+171.97%
3 Months:	+115.64%
1 Month:	+17.71%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish

52-Week Range 91% of range

$32.15 $118.32

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMAAbove
RSI (14)65.73 · Neutral

Price Performance

1M+17.71%

3M+115.64%

6M+171.97%

1Y+54.23%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Compounding revenue at 118.8% over 5 years.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Trading at a high P/E of 135.0.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

134.99

Industry PE

Forward P/E est.

191.29

PEG Ratio

Book Value

$4.55

Price to Book

24.35

P/S

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

118.75%

Profit 5Y

1.14%

Revenue (YoY)

12.79%

Earnings (YoY)

-29.43%

Profitability & Returns

ROCE

6.68%

ROE

15.38%

ROA

11.91%

Profit Margin

13.09%

Op Margin

5.88%

Gross Margin

98.30%

EPS (Latest Qtr)

$0.36

EPS (TTM)

$0.82

Balance Sheet & Liquidity

Debt/Equity

0.94

Quick Ratio

2.85

Current Ratio

2.92

Debt

$6.11M

Total Assets

$888.70M

Current Assets

$485.46M

Working Capital

$319.38M

Ownership

Promoter Holding

Chg in Prom Hold

FII / Inst Holding

Chg in FII Hold

Financial Snapshot

Enterprise Value

Total Revenue (TTM)

$761.41M

EBITDA

$46.69M

Free Cash Flow

$141.78M

Operating Cash Flow

$142.00M

Shares Outstanding

142.52M

Gross Margin

98.30%

Payout Ratio

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-	-	27.60M	35.56M	42.76M	53.28M	57.66M	62.31M	64.44M	66.83M	64.83M	72.26M	81.50M	87.89M	93.25M	88.56M	86.33M	85.73M	79.44M	91.59M	96.13M	93.69M	103.39M	101.73M	105.65M	117.72M	123.60M	146.81M	163.80M	182.55M	-	-	194.43M	207.64M	202.12M	164.90M	256.15M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.43M	4.60M	2.54M	2.88M	4.06M
Gross Profit	14.60M	15.66M	19.30M	21.06M	23.25M	26.95M	34.78M	41.79M	52.12M	56.48M	61.16M	63.14M	65.25M	63.59M	70.88M	80.05M	86.46M	91.37M	87.33M	85.11M	84.48M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	191.00M	203.04M	199.58M	162.02M	252.09M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	164.32M	192.82M	195.09M	211.62M	210.79M
Operating Income	-	592.00K	1.51M	3.07M	-	4.74M	12.79M	13.62M	-	21.00M	20.63M	22.97M	-	18.96M	24.63M	33.00M	-	37.71M	35.26M	24.72M	-	19.64M	31.94M	36.23M	26.77M	31.43M	31.93M	14.85M	29.58M	31.18M	29.50M	35.59M	46.60M	-	-	26.68M	10.22M	4.49M	-49.60M	41.30M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27.14M	10.70M	4.97M	-49.00M	42.16M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31.69M	15.24M	9.91M	-44.72M	45.93M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3.46M	-4.42M	-14.38M	-12.95M	2.94M
Net Income	959.00K	-19.00K	977.00K	2.58M	4.60M	4.39M	12.65M	13.76M	98.33M	17.46M	18.20M	17.75M	22.01M	18.27M	20.19M	26.34M	29.38M	30.07M	28.33M	21.62M	25.99M	23.46M	26.52M	30.47M	22.80M	27.41M	34.61M	15.88M	27.53M	31.38M	27.76M	35.49M	47.21M	-	-	35.15M	19.67M	24.29M	-31.76M	42.99M
Diluted EPS	-	-	0.01	0.02	-	0.04	0.10	0.11	0.77	0.14	0.14	0.14	0.18	0.15	0.17	0.22	0.24	0.25	0.23	0.17	0.20	0.18	0.21	0.24	0.20	0.24	0.30	0.14	0.25	0.28	0.25	0.32	0.41	-	-	0.29	0.16	0.20	-0.30	0.36
R&D Expense	-	4.63M	5.67M	7.05M	-	7.18M	7.88M	11.69M	-	17.05M	20.54M	18.86M	-	20.24M	21.66M	22.80M	-	26.12M	26.50M	33.87M	-	29.02M	28.23M	28.09M	28.12M	32.83M	33.29M	40.85M	43.28M	45.52M	58.51M	58.74M	59.34M	-	60.73M	60.47M	68.85M	-	66.27M	53.89M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2000	Dec 2001	Dec 2002	Dec 2003	Dec 2004	Dec 2005	Dec 2006	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	-	-	29.00K	-	-	3.31M	10.36M	26.55M	50.29M	81.32M	159.20M	251.25M	306.49M	353.87M	-	401.86M	482.38M	675.04M	761.41M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.38M	6.48M	10.88M	12.98M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	396.47M	475.89M	664.16M	748.43M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	283.84M	368.61M	527.21M	703.63M
Operating Income	-	-	-	-	-	-	-	-	-	-20.25M	-27.44M	-32.33M	-36.27M	-41.50M	-27.62M	-3.44M	10.18M	52.85M	89.50M	111.61M	128.20M	-	112.63M	107.28M	136.95M	44.80M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	116.08M	109.64M	138.29M	46.69M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	116.19M	124.56M	161.49M	66.46M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14.77M	18.42M	20.28M	-33.19M
Net Income	-1.85M	-7.45M	-18.50M	-9.81M	-15.54M	-20.09M	-24.87M	-11.57M	-20.06M	-20.17M	-25.97M	-32.35M	-38.05M	-46.01M	-31.38M	-6.41M	8.14M	129.12M	75.41M	94.18M	106.01M	-	101.42M	106.14M	141.21M	99.65M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.06	0.07	1.04	0.60	0.77	0.85	-	0.87	0.94	1.23	0.82
R&D Expense	-	-	-	-	-	-	-	-	-	14.40M	18.95M	21.00M	14.07M	20.47M	18.37M	15.42M	23.84M	40.38M	75.25M	89.02M	114.76M	113.86M	130.99M	184.35M	246.89M	254.91M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 1999	Dec 2000	Dec 2001	Dec 2002	Dec 2003	Dec 2004	Dec 2005	Dec 2006	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	-	-	-	-	-	-	-	-	-	25.10M	39.83M	99.17M	63.08M	34.63M	51.90M	68.75M	220.54M	311.69M	412.31M	571.73M	-	583.43M	621.52M	840.55M	836.65M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	499.25M	458.64M	471.60M	485.46M
Cash & Equivalents	-	-	-	-	-	-	-	-	-	14.72M	23.87M	24.58M	39.63M	93.03M	54.88M	24.25M	40.44M	51.54M	31.06M	41.62M	31.27M	76.19M	-	66.33M	135.55M	127.67M	120.50M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.10M	7.73M	12.41M	12.87M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31.06M	41.12M	53.98M	59.79M
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29.57M	35.81M	41.13M	48.39M	-	81.59M	114.81M	160.96M	188.85M
Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	3.86M	5.03M	8.36M	12.74M	13.55M	20.88M	27.37M	29.57M	35.57M	38.84M	47.49M	-	72.49M	104.50M	140.77M	166.09M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	29.03M	29.32M	24.46M	12.53M	0	0	-	-	-	-	-	-	-	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.14M	151.00K	6.94M	6.11M
Total Equity	-244.00K	-2.00M	-7.54M	-21.94M	-31.47M	45.95M	26.59M	6.36M	14.73M	16.91M	22.09M	21.24M	34.81M	61.78M	21.02M	-3.39M	18.50M	41.38M	190.97M	275.88M	371.18M	523.34M	-	501.84M	506.70M	679.59M	647.80M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	130.96M	134.34M	137.75M	142.52M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-17.97M	-22.29M	-27.40M	-36.02M	-37.06M	-	-	18.39M	60.94M	115.67M	136.12M	151.97M	167.89M	120.32M	126.68M	198.29M	142.00M
Investing Cash Flow	3.59M	-	-25.00K	-151.00K	-127.00K	-	-	-194.00K	-73.46M	-90.77M	-117.83M	-119.26M	136.13M	-114.33M	90.91M	-177.60M	69.76M
Financing Cash Flow	23.52M	23.00M	42.48M	89.57M	-970.00K	-	-	-7.10M	-7.95M	-14.34M	-28.64M	12.21M	-302.59M	-17.28M	-148.72M	-28.35M	-220.37M
Capital Expenditure	-	-	-25.00K	-151.00K	-127.00K	-174.00K	-17.00K	-194.00K	-419.00K	-298.00K	-1.09M	-1.24M	-469.00K	-413.00K	-139.00K	-2.17M	-211.00K
Free Cash Flow	-	-	-27.43M	-36.17M	-37.19M	-	-	18.20M	60.52M	115.37M	135.03M	150.73M	167.42M	119.91M	126.54M	196.12M	141.78M
Share Buybacks	-	-	-	-	-	-	-	0	0	23.66M	30.98M	9.95M	-	0	0	15.66M	172.91M

Ratios (Annual)

Figures in %.

Metric	Dec 2000	Dec 2001	Dec 2002	Dec 2003	Dec 2004	Dec 2005	Dec 2006	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	98.7%	98.7%	98.4%	98.3%
Operating Margin %	-	-	-	-	-	-	-	-	-	-69,827.6%	-	-	-1,096.8%	-400.7%	-104.0%	-6.8%	12.5%	33.2%	35.6%	36.4%	36.2%	-	28.0%	22.2%	20.3%	5.9%
Net Margin %	-	-	-	-	-	-	-	-	-	-69,537.9%	-	-	-1,150.5%	-444.3%	-118.2%	-12.7%	10.0%	81.1%	30.0%	30.7%	30.0%	-	25.2%	22.0%	20.9%	13.1%
ROE %	92.3%	98.9%	84.3%	31.2%	-33.8%	-75.6%	-391.1%	-78.5%	-118.7%	-91.3%	-122.2%	-93.0%	-61.6%	-218.9%	926.3%	-34.6%	19.7%	67.6%	27.3%	25.4%	20.3%	-	20.2%	20.9%	20.8%	15.4%
ROCE %	-	-	-	-	-	-	-	-	-	-	-129.2%	-92.9%	-39.9%	-82.4%	-131.1%	-11.1%	24.6%	27.7%	32.4%	29.9%	24.5%	-	22.0%	20.8%	19.6%	6.7%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CORT

Google News Wed, 05 Aug 2026

We Think That There Are More Issues For Corcept Therapeutics (NASDAQ:CORT) Than Just Sluggish Earnings - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxPUUdGYWFLSEtvZjBFcFd6M3dBMzZKVEduWWoxQXhrczhXOEJlQTBRSlR4SHRtUUpiU1RPUDFGMHl4NzVxVjNJQmVmRGVzbkw0WlVydVFDVnZhOEFZZ0M5VF9sTTlrRlhoWU9HaUJ2RXk0dWcxOFBGcGVqOTBORlFGTVBSaTQxODZIU2dfTU…

Google News ue, 04 Aug 2026

CORT (NASDAQ: CORT) insider schedules 20,000-share option-related sale - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxPem04UjZXaDRvaGZuTzRMSTlmc05WbGxRcl91dGJnZHB3aGRWby1EaVJRLUVyY0FOSUtKRTE0X0gtRTRIck02YTMxY1RKSDkweXMzT1dDM3RfUXdNeF80NGtISnBOMHQzd3g0N3JxMmJ2TWh0RDZNNzNOOWtPUkxsbU1EZnF0LV9jenhFbF…

Google News ue, 04 Aug 2026

CORT Stock Skyrockets 35% After Early FDA Nod For Ovarian Cancer Drug - Stocktwits

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPVXV0cUFJeGN4bXpXRjU5MGhqdDRVVWxDQ1VyZnROWnFGNTlfM29WV3JyVEZkRG1rVWtIaDFWaGRuR2w5UGxsc0hEZWpOX1hPZTdsOG55TFZ3N3cyX3BnNFllODZOa1Q4YmtKLXU4ZjlkSlhKbnRrZXJ3TmxVaTRTWG93SzMtcGZUeFd5aF…

Google News Mon, 27 Jul 2026

Why Corcept (CORT) Stock Is Down Today - StockStory

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQX2hCVDVpOWoyS2FmZ19nZ0hmLUhCZDZOSm9IRGd6NGt2STlUbGplWk5YbUtQeERnZVRyd2NmNHo0VllVQ3VUNVhqenduZXVIdFhybFR1MDhLSnoyRkdnUEI1ZE9ydFo2NV9DbmdCT1RORFpZbDQ1RktSTERsTk1ZMTZUazFsUUF1dFkyTU…

Google News Wed, 05 Aug 2026

Corcept Therapeutics' (NASDAQ:CORT) Anemic Earnings Might Be Worse Than You Think - Moomoo

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNVUdteEpZWUx5ZVhnaGhmT2twb2JXYnlJWFNrSUdqNjVzV3B6RGg5QzRFcFNTS1VDSm5aS0VQTTZGWmZ5U2hvZUh4TEc4MDdvUll2cUFtSG9XSGhkWlAyMjJ2QWlWaGxvQ1MxOHJRQ0xnRkNmM2lkU0hsSW9TNHVCSUpGNi1kZzB1MGhTS0…

Google News Mon, 08 Jun 2026

CORT Stock Rises 42% in a Month: Here's What You Should Know - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQUVROdk84TDhNUWgxVFRaeWRVQmhmNWtKbF9LdDQ5ZHpHWThYVTJKTjFmY3U3UkVFV2xnQk1PU3J2Z0xPQ3RqcjRGNE9xZC1WaVcxN0FoblBldWZWQ0JjV2NUSUxHZ2FNNUtOUEs2YjcwbUJCVVlVQndLMG8yYkRsWERGa01vdE1ZT3k4Y2…

CORT — Frequently Asked Questions

What is the current share price of CORT?

As of 2026-08-05 17:25 PDT, CORT trades at $110.69 on NASDAQ/NYSE. Its 52-week range is $32.15 to $118.32.

What is the market capitalisation of CORT?

CORT has a market capitalisation of $15.78B on NASDAQ/NYSE.

What is the P/E ratio of CORT?

CORT trades at a trailing price-to-earnings (P/E) ratio of 134.99. Its price-to-book (P/B) ratio is 24.35.

What is the return on equity (ROE) of CORT?

CORT has a return on equity (ROE) of 15.38%. Its return on capital employed (ROCE) is 6.68%.

Is CORT a good stock to buy?

This page provides a data-driven analysis of CORT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

CORT CORT

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Analyst View

Latest News

We Think That There Are More Issues For Corcept Therapeutics (NASDAQ:CORT) Than Just Sluggish Earnings - simplywall.st

CORT (NASDAQ: CORT) insider schedules 20,000-share option-related sale - Stock Titan

CORT Stock Skyrockets 35% After Early FDA Nod For Ovarian Cancer Drug - Stocktwits

Why Corcept (CORT) Stock Is Down Today - StockStory

Corcept Therapeutics' (NASDAQ:CORT) Anemic Earnings Might Be Worse Than You Think - Moomoo

CORT Stock Rises 42% in a Month: Here's What You Should Know - Yahoo Finance

CORT — Frequently Asked Questions

What is the current share price of CORT?

What is the market capitalisation of CORT?

What is the P/E ratio of CORT?

What is the return on equity (ROE) of CORT?

Is CORT a good stock to buy?

Explore More